Is ADAP A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Adaptimmune Therapeutics Plc (ADAP)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Matrix Capital Management David Goel And Paul Ferri | 38,974,185 | $206,953 | 2.38% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 9,830,877 | $52,202 | 0.22% | |
| 3. | VenBio Select Advisor Kurt Von Emster | 3,550,000 | $18,851 | 0.32% | |
| 4. | Partner Fund Management Christopher Medlock James | 2,501,303 | $13,282 | -8% | 0.4% |
| 5. | Citadel Investment Group Ken Griffin | 2,475,552 | $13,145 | +29% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.79 | 12,600 | Director | 12,600 | 2021-06-01 | Filing | |
| $0.69 | 24,000 | Officer | 57,000 | 2020-12-14 | Filing | |
| $0.69 | 207,000 | Officer | 284,808 | 2020-12-14 | Filing | |
| $1.62 | 33,000 | Officer | 33,000 | 2020-06-29 | Filing | |
| $1.89 | 12,900 | Director | 12,900 | 2020-06-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.58 | 2,939 | Officer | 4,873 | 2021-08-02 | Filing | |
| $4.37 | 2,794 | Officer, Director | 3,058 | 2021-06-28 | Filing | |
| $5.67 | 2,111 | Officer | 3,539 | 2021-01-19 | Filing | |
| $5.67 | 4,358 | Officer | 7,346 | 2021-01-19 | Filing | |
| $5.67 | 9,879 | Officer, Director | 13,529 | 2021-01-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 17,082,611 | $72,772 | 0.94% | |
| 2. | 11,696,919 | $49,828 | 0.02% | |
| 3. | 513,388 | $2,187 | 0.24% | |
| 4. | 432,921 | $1,844 | 0.02% | |
| 5. | 121 | $468 | 0% |
News See All
Hedge Funds Have Never Been This Bullish On Adaptimmune Therapeutics plc (ADAP)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should You Buy Adaptimmune Therapeutics plc (ADAP)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Is Adaptimmune Therapeutics plc (ADAP) Going To Burn These Hedge Funds ?
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Is Adaptimmune Therapeutics plc (ADAP) Is Burning These Hedge Funds
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is Adaptimmune Therapeutics plc (ADAP) Going to Burn These Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Fund and Insider Trading News: Anthony Scaramucci, Solus Alternative Asset Management, Adaptimmune Therapeutics PLC (ADAP), Motorola Solutions Inc (MSI), BK Technologies Inc (BKTI), and More
Anthony Scaramucci, founder of hedge fund SkyBridge Capital and the Trump administration's White House communications director for 10 days in 2017, is selling his Southampton, New York beach house for...
Hedge Fund and Insider Trading News: Elliott Management, HG Vora Capital Management, OncoCyte Corp (OCX), Solaredge Technologies Inc (SEDG), Autodesk, Inc. (ADSK), and More
Commvault, a provider of backup and recovery software, will soon find itself in a proxy battle with Elliott Management. Elliott plans to nominate four directors for Commvault's 11 member board.
13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC – ADR (ADAP)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
Market Movers Today: Solid Biosciences Inc (SLDB), Adaptimmune Therapeutics PLC – ADR (ADAP), Snap Inc (SNAP), Image Sensing Systems, Inc. (ISNS), and More
What happened: Shares of Solid Biosciences Inc.
Billionaire Hedge Funds
